Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE4

מצבים רפואיים

Breast Cancer

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang, China
Contact: Study coordinator (Xuesong Chen) · cxs1978@163.com · +8615804500816
Contact: Principal Investigator (Xuesong Chen)
The Second Hospital of Jilin University, Changchun, Jilin, China
Contact: Study coordinator (Yingchao Zhang) · zhang_yc@jlu.edu.cn
Contact: Principal Investigator (Yingchao Zhang)
Dalian Municipal Central Hospital, Dalian, Liaoning, China
Contact: Study coordinator (Wenbin Guo) · drguowb@hotmail.com · +8613079850586
Contact: Principal Investigator (Wenbin Guo)
Panjin Liaohe Oilfield Gem Flower Hospital, Panjin, Liaoning, China
Contact: Study coordinator (Hongbin Han) · rose_030201@163.com · +8613704236001
Contact: Principal Investigator (Hongbin Han)
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Contact: Study coordinator (Caigang Liu) · liucg@sj-hospital.org · +86 18940254967
Contact: Study coordinator (Rong Wu) · wur@sj-hospital.com · +86 18940251156
Contact: Principal Investigator (Caigang Liu)
Contact: Principal Investigator (Rong Wu)
The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China
Contact: Study coordinator (Wei Tu) · cmu4htw@126.com · +8618900913000
Contact: Principal Investigator (Wei Tu)
Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China
Contact: Study coordinator (Hong Xu) · xh4015@163.com · +8618900917779
Contact: Principal Investigator (Hong Xu)

מובילי המחקר